Health
COVID-19: Trials begin of new antibody treatment to prevent infection soon after exposure – Republic World
A new antibody treatment is being trialed in hopes that it could prevent people from developing COVID-19 after being exposed to the disease
Amid surge in coronavirus cases across the world, a new antibody treatment is being trialled in hopes that it could prevent people from developing the deadly virus after being exposed to the disease. According to SkyNews, the antibody, known as AZD7442, has been developed by UK-based pharmaceutical company AstraZeneca and is now being looked by the University College London Hospitals NHS Trust as part of a new trial called ‘Storm Chaser’. So far, ten people have been injected with the new antibody…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants